Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/12/2005EP1583535A2 Methods for treating diabetes
10/12/2005EP1583534A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/12/2005EP1583533A1 Use of piperazine derivatives as ccr1 antagonists
10/12/2005EP1583530A1 2-aminothiazole allosteric enhancers of a1-adenosine receptors
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1583528A1 Nf-kb inhibitors and uses thereof
10/12/2005EP1583527A1 Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
10/12/2005EP1583526A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
10/12/2005EP1583525A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
10/12/2005EP1583524A1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
10/12/2005EP1583523A1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
10/12/2005EP1583522A1 Use of cyclin d1 inhibitors
10/12/2005EP1583521A1 Use of hypericin and/or the derivatives thereof for the prevention of primary tumours
10/12/2005EP1583514A2 Increasing skin cell renewal with water-soluble vitamin e
10/12/2005EP1583507A2 Magnesium salt of imidazole derivative
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1583458A2 Lipophilic electrophoretic probes
10/12/2005EP1494659B1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/12/2005EP1482939A4 Preparation of paroxetine involving novel intermediates
10/12/2005EP1478362B1 A combination treatment for acute myocardial infarction
10/12/2005EP1448196B1 Benzothiazole derivatives as adenosine receptor ligands
10/12/2005EP1414819B1 THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
10/12/2005EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/12/2005EP1370568B1 Chemical compounds
10/12/2005EP1359943B1 Biotin-derivates and their conjugates with chelating agents
10/12/2005EP1347763A4 Neuroactive steroid derivatives and methods of use
10/12/2005EP1335747A4 A composition of sodium channel blocking compound
10/12/2005EP1313749B1 Process for preparation of anhydrous azithromycin
10/12/2005EP1313485B1 Use of an aldosterone receptor antagonist to improve cognitive function
10/12/2005EP1313467B1 Novel pharmaceutical composition for administering n-0923
10/12/2005EP1294360B1 Process for the preparation of crystalline particles for inhalation
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1272195B1 Use of fulvestrant in the treatment of resistant breast cancer
10/12/2005EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
10/12/2005EP1242096B1 Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1212106B1 Phospholipid-coated implants
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP1202964B1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005EP1185249B1 Use of a biodegradable polymer
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP1163219B1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
10/12/2005EP1162890B1 A method of preventing parturient hypocalcemia in animals and compositions used therein
10/12/2005EP1158977B1 Composition for administering a cyclooxygenase-2 inhibitor to animals
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity
10/12/2005EP1140848B1 Phenethyl-5-bromopyridylthiourea (pbt) derivatives exhibiting spermicidal activity
10/12/2005EP1140033B1 Improved controlled release compositions
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1137414B1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
10/12/2005EP1128822B1 Antioxidant compositioncomprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP1100787B1 Lipid-lowering quinazoline derivative
10/12/2005EP1072269B1 Use of dextrin, starch or glycogen for the treatment of bacterial vaginosis
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP1049793B1 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
10/12/2005EP1001772B1 Improved delivery of multiple doses of medications
10/12/2005EP0999834B1 Antithrombotic agents
10/12/2005EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/12/2005EP0946170B1 Diclofenac for the treatment of vasculopathies
10/12/2005EP0900085B1 Treatment of excessive aggression with olanzapine
10/12/2005EP0814842B1 Method for treating amyloidosis
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005EP0760240B1 Composition for stimulating the cerebral activity comprising vinpocetine citrate and a plant extract comprising xanthines
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681941A Methods for the treatment of dementia based on APOE genotype
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681821A Antidepressivt virkende cykloalkylaminderivater AV heterocykle-kondenserte benzodioksaner
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681814A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via 1H-imidazo [4, 5-C] quinolin-4-phthalimide intermediates
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681808A N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681802A Lansoprazole polymorphs and processes for preparation thereof
10/12/2005CN1681800A Process for preparing prostaglandin derivatives and starting materials for the same
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681794A Preventive and/or therapeutic drugs for inflammatory intestinal diseases
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681784A Azabicyclo derivatives as muscarinic receptor antagonists
10/12/2005CN1681781A 新的二氢吲哚化合物和其医药用途 New indoline compound and pharmaceutical use
10/12/2005CN1681779A 4-pyrrolidino-phenyl-benzyl ether derivatives
10/12/2005CN1681778A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681777A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681774A Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2, 6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
10/12/2005CN1681771A 4-(3, 3-dihalo-allyloxy)phenoxy alkyl derivatives
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681536A Method of preparing dry powder inhalation compositions
1 ... 4508 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 ... 7860